Authors


Susan Sloane, RPh, CDE, CPT

Latest:

Chronic Care Focus: Controlling Diabetes in the ICU

Implementing effective insulin protocols and sharing best practices can improve glycemic control for patients in hospitals and long-term care.


Mark Calarco, MD, National Medical Director for Clinical Diagnostics, American Addiction Centers

Latest:

Opioid Overdoses Are Rising: Is Your Pharmacy Equipped?

The pandemic is exacerbating many of the conditions that contribute to relapse or people using substances just to cope, including unemployment, stress, fear, anxiety, and isolation.


Jayson Slotnick, JD, MPH

Latest:

The Growth of the 340B Drug Pricing Program

Incentives in the 2010 health care law have encouraged consolidation in the health care marketplace toward a more cost-conscious managed health care market.



Rebecca Lehto, PhD, RN

Latest:

Updates on Using Mindfulness Interventions to Manage Pain

Pain is recognized as a common, but complex, multifaceted experience that can interfere with quality of life and contribute to psychological problems, social awkwardness, and work-related disability.


Jane Shtaynberg, PharmD

Latest:

New Dimensions for Preferred Careers in Pharmacy

It is estimated that more than four billion prescriptions are filled in pharmacies across the US on an annual basis.


Ann Haynos, BA

Latest:

Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting Strategy

This prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.


Kate Ressler

Latest:

Bad Math: The Impact of Medication Dosage Miscalculations

Technology has enhanced our ability to detect many types of medication errors, but human errors, especially those involving calculations, continue to be a problem.




Woody Eisenberg, MD

Latest:

What Roles Do Patient Characteristics Play in Value-Based Performance?

Incorporating patient-related sociodemographic factors into performance measurement systems is essential for providing an accurate assessment of the quality of care delivered.


Ashley L. Pappas, PharmD, BCPS

Latest:

Entyvio by Takeda Pharmaceuticals

Entyvio, manufactured by Takeda Pharmaceuticals, was approved in May 2014 for the treatment of adult patients with moderate to severe ulcerative colitis or Crohn's disease.


Johnathan Jernigan, 2017 PharmD candidate

Latest:

Management of Opioid-Induced Constipation

Prescription opioids are potent pain-relieving medications that, when used correctly, can effectively control pain and increase quality of life for patients with acute or chronic pain.


Orsolya E. Lunacsek, PhD, MBA

Latest:

Adherence and Persistence of Bimatoprost in Prior Latanoprost Users

A new ophthalmic formulation of bimatoprost was found to improve adherence and persistence compared with the original formulation of bimatoprost.


Howard S. Friedman, PhD, MMS

Latest:

Effectiveness of Ezetimibe Monotherapy in Patients With Hypercholesterolemia

The effectiveness of ezetimibe monotherapy for lowering low-density lipoprotein cholesterol was assessed in a managed care population.


April Miller Quidley, PharmD, BCPS, FCCM, PGY-2

Latest:

The Ins and Outs of Residency Applications

As the demand for residency pharmacy programs grows, here are some tips on how to navigate the application process.


Casandra A. Holveck

Latest:

Busting Barriers: Improving Adult Immunization Rates

In a survey of 512 people, 15.2% said they believed that adults do not need to be vaccinated.


Joseph J. Carreno, PharmD, MPH

Latest:

Many Platforms Offer Rapid Detection in Bloodstream Infections

Institutions should consider optimal targets, testing volumes, and notification and reporting practices when making their choice.



Eric Sredzinski, PharmD

Latest:

Managing Pain While Minimizing Risk: The Growing Role of Specialty Pharmacy in Pain Management

Physician and pharmacist collaboration is key within the complex pain management prescribing landscape.


Peter K. Sand, MD

Latest:

Comparing Direct Medical Costs of OnabotulinumtoxinA With Other Common Overactive Bladder Interventions

This cost analysis demonstrated that onabotulinumtoxinA is one of the least-costly treatment options for inadequately managed overactive bladder syndrome.


Olivia Bentley, PharmD, AAHIVP, CFTS

Latest:

Pharmacogenetics in Psychiatry: Misconceptions, Challenges, and Successes

Pharmacogenetics has the potential to radically change the practice of psychiatry.




Sarjit Patel, PharmD

Latest:

The Specialty Pharmacy's Role in Ensuring the Effectiveness of New Hepatitis C Drugs

Breakthrough hepatitis C drugs promise cure rates upwards of 90%, and specialty pharmacy can play an important role in their success by addressing obstacles to adherence.


Majorie L. M. Mau, MD, MS

Latest:

Association Between Sustained Glycated Hemoglobin Control and Healthcare Costs

Total cost of care for patients whose glycated hemoglobin levels were



Grace E. Lee, 2016 PharmD Candidate

Latest:

How to Make the Most of Your Community Rotation

Here are 3 ways to make the most of your community rotation experience.


Thomas Castles

Latest:

Once-Daily COPD Triple Therapy Gets FDA Approval

Fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta) is a single-inhaler triple therapy for the long-term, maintenance treatment of patients with chronic obstructive pulmonary disease.


Alan Polnariev, PharmD, MS, CGP

Latest:

How a Bucket of Chicken Can Help Achieve Any Goals We Have (Part 3)

Committing to each part of this principle and following these guidelines will help achieve success.